CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells

CXCL9 和 CXCL10 通过促进浆细胞分化，增强了 COVID-19 康复后出现急性呼吸窘迫综合征患者的体液免疫反应；此外，CXCL9 还能诱导 T 辅助细胞上 CD40L 和 CXCR3 的表达上调。